The International Cardio-Oncology Society has released new guidelines for managing cancer therapy-related cardiac dysfunction, addressing educational gaps identified in a survey of 220 healthcare providers. The survey found highest educational needs for topics like immune checkpoint inhibitor-associated myocarditis and atrial fibrillation management.
A study finds nearly half of melanoma patients receiving BRAF or MEK inhibitors develop hypertension or cardiac dysfunction. Moderate to severe cardiac issues appear within 4 weeks and only in patients with medium or higher baseline risk. Higher baseline NT-proBNP levels are associated with increased cardiac dysfunction risk.
| NCT ID | Title | Status | Phase |
|---|---|---|---|
| NCT07622394 |
Structured Cardio-Oncology Rehabilitation for Cardiovascular Outcomes in Cancer Survivors |
NOT_YET_RECRUITING | NA |
| NCT06610019 |
Cardiovascular Multimodality Imaging Study |
RECRUITING |
